Webinars

  • Fragment Screening: Save time and sample with Spectral Shift technology18:36

    Fragment Screening: Save time and sample with Spectral Shift technology

    Many methods used in fragment-based drug discovery pose real challenges — SPR often struggles to detect true hits due to fragments’ small mass, DSF can have high rates of false positives, and NMR equi

    Watch
  • De-risk your antibody characterization workflows with high-quality, multi-parameter stability data from Prometheus Panta16:24

    De-risk your antibody characterization workflows with high-quality, multi-parameter stability data from Prometheus Panta

    Get developability profiles for monoclonal antibodies with stability data from Prometheus Panta to inform on rational design and selection of therapeutic constructs that will succeed in the clinic.

    Watch
  • Biologics Formulation: Select optimal buffer conditions with multi-parameter stability characterization from Prometheus Panta22:59

    Biologics Formulation: Select optimal buffer conditions with multi-parameter stability characterization from Prometheus Panta

    Learn how to identify optimal buffer conditions during pre-formulation, with multi-parameter stability characterization from Prometheus Panta, a tool to collect thermal and colloidal data while saving

    Watch
  • Assess the impact of bioconjugation with multi-parameter stability characterization17:08

    Assess the impact of bioconjugation with multi-parameter stability characterization

    Characterize the developability of antibody-drug conjugates: Multi-parameter stability assessment with Prometheus Panta makes it possible to examine multiple aspects of ADC stability in parallel.

    Watch
  • How stability prediction experiments give you confidence in your ADCs19:07

    How stability prediction experiments give you confidence in your ADCs

    For antibody-drug conjugate (ADC) development, scientists rely on stability experiments using fluorescence and light scattering techniques to predict the conjugated molecule's behavior.

    Watch
  • The power of Monolith X for Characterizing GPCRs: Accelerating Binding Affinity Measurements20:31

    The power of Monolith X for Characterizing GPCRs: Accelerating Binding Affinity Measurements

    To understand signaling pathways, Spectral Shift technology allows for accurate bindings affinity measurements of membrane proteins like GPCRs in close to native conditions.

    Watch
  • The use of Spectral Shift in identifying Microcycle® hits for challenging therapeutic targets14:18

    The use of Spectral Shift in identifying Microcycle® hits for challenging therapeutic targets

    Transcription factors have traditionally been considered challenging therapeutic targets. Their intrinsic disorder and lack of small molecule binding pockets make them intractable to small molecule ap

    Watch
  • Applying Spectral Shift technology to study IDPs: Direct binding and displacement assays of MYC:MAX inhibitors11:48

    Applying Spectral Shift technology to study IDPs: Direct binding and displacement assays of MYC:MAX inhibitors

    MYC is an important therapeutic target that associates with MAX to regulate gene transcription. Its lack of binding pockets and the presence of disordered regions make it a difficult protein to study

    Watch
  • Conversation:  How Aaron Frimel from Thermo Fisher Scientific approaches biologics formulation38:20

    Conversation: How Aaron Frimel from Thermo Fisher Scientific approaches biologics formulation

    Join this conversation to gain insight into how the Analytical and Formulation Sciences team at Thermo Fisher Scientific approaches stability assessment of biologic, and how the Prometheus Panta helps

    Watch
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • How to mitigate risk during ADC development with multi-parameter stability characterization19:16

    How to mitigate risk during ADC development with multi-parameter stability characterization

    To assess the developability properties of antibody-drug conjugates (ADCs) learn about multi-parameter characterization of thermal and colloidal stability with Prometheus Panta using nanoDSF and DLS

    Watch
  • nanoDSF for biologics: How to interpret thermal unfolding profiles for your different applications38:31

    nanoDSF for biologics: How to interpret thermal unfolding profiles for your different applications

    Thermal stability screening is a common approach used to study the developability of a wide range of protein-based therapeutics. Among the different technologies available to perform thermal stability

    Watch
  • Thermal stability measurements for biologics developability profiling24:28

    Thermal stability measurements for biologics developability profiling

    Learn about four methods for thermal stability measurements: DSC, CD, DSF and nanoDSF. You'll review their pros and cons, what they data tell you and why it's important for biologics developability.

    Watch
  • Contact Specialist
  • Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift22:23

    Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

    Chances are your company’s research and development pipeline includes several PROTAC candidates — placing you with many others in the race to bring successful and efficient protein degraders to the cl

    Watch
  • Explore Prometheus Panta – Frequently asked questions about stability profiling experiments8:38

    Explore Prometheus Panta – Frequently asked questions about stability profiling experiments

    In this video, Nathan Wallace, Application Specialist at NanoTemper, addresses common questions about experimental design for developability profiling and the operation of Prometheus Panta.

    Watch
  • Explore Prometheus Panta – Biologics developability assessment with four integrated technologies20:19

    Explore Prometheus Panta – Biologics developability assessment with four integrated technologies

    Developability assessment is a critical part of the evaluation and selection of candidates for further optimization and development for biologics researchers. This work entails collecting, ranking, an

    Watch
  • How to keep your degrader pipeline moving forward with Dianthus16:42

    How to keep your degrader pipeline moving forward with Dianthus

    The development of your protein degrader is a multi-step and complex process usually packed with challenges that if left unsolved will delay the progress of your project. What if you could overcome co

    Watch
  • How biologics teams approach developability screening of their candidates with combinatorial stability characterization21:31

    How biologics teams approach developability screening of their candidates with combinatorial stability characterization

    Full developability profiles de-risk the selection process for biologics candidates during early development workflows. There are many critical quality attributes to evaluate when it comes to developa

    Watch
  • How to use light scattering techniques to predict your biologic's self-association behavior at high concentrations17:33

    How to use light scattering techniques to predict your biologic's self-association behavior at high concentrations

    Developability work requires the assessment of multiple critical quality attributes (CQAs) of your biologics. Many of these CQAs are measured or monitored using low-volume, low-concentration samples.

    Watch
  • How biologics teams use Dynamic Light Scattering to identify leading candidates13:12

    How biologics teams use Dynamic Light Scattering to identify leading candidates

    Watch this 15 min video to learn how groups in early biologics development and formulation use Dynamic Light Scattering (DLS) to make informed decisions that de-risk downstream biologics development.

    Watch
  • Overcome bottlenecks in viral vector manufacturing25:08

    Overcome bottlenecks in viral vector manufacturing

    The success of your gene therapy vectors is dependent on optimal formulation conditions. Finding a buffer that provides better long-term stability for AAVs is a crucial step in the process of developi

    Watch
  • loading
    Loading more...